Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference

Cencora executives highlighted its specialty-pharmaceutical positioning, medical-specialty organization strategy, and capital-allocation priorities at an investor conference. The company also reaffirmed the durability of its relationship with Walgreens, supporting confidence in a key commercial partnership, though no new financial targets or quantitative updates were disclosed.